Founders Financial Alliance, LLC Abb Vie Inc. Transaction History

Founders Financial Alliance, LLC

$356 Million
Q4 2024

A detailed history of Founders Financial Alliance, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Founders Financial Alliance, LLC holds 18,030 shares of ABBV stock, worth $3.48 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

18,030

Previous 19,480 7.44%

Holding current value

$3.48 Million

Previous $3.85 Million 16.72%

% of portfolio

0.9%

Previous 1.09%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$164.99 - $203.87 $239,235 - $295,611	-1,450 Reduced 7.44%	18,030 $3.2 Million
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $52,101 - $63,386	-318 Reduced 1.61%	19,480 $3.85 Million
Q2 2024 Aug 23, 2024	SELL	$154.79 - $180.76 $6,036 - $7,049	-39 Reduced 0.2%	19,798 $3.4 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $2,077 - $2,367	13 Added 0.07%	19,837 $3.61 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $68,249 - $76,865	496 Added 2.57%	19,824 $3.07 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $92,310 - $106,863	-691 Reduced 3.45%	19,328 $2.88 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $66,520 - $82,779	502 Added 2.57%	20,019 $2.7 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $22,125 - $25,480	153 Added 0.79%	19,517 $3.11 Million
Q4 2022 Feb 15, 2023	BUY	$138.31 - $165.87 $12,862 - $15,425	93 Added 0.48%	19,364 $3.13 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.37 Million - $1.57 Million	10,221 Added 112.94%	19,271 $2.59 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $1.2 Million - $1.53 Million	-8,751 Reduced 49.16%	9,050 $1.39 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $152,832 - $189,622	-1,158 Reduced 6.11%	17,801 $2.89 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $230,759 - $291,977	2,148 Added 12.78%	18,959 $2.57 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $14,044 - $15,942	132 Added 0.79%	16,811 $1.81 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $26,933 - $30,005	256 Added 1.56%	16,679 $1.88 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $151,710 - $167,015	1,483 Added 9.93%	16,423 $1.84 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $228,350 - $308,296	2,837 Added 23.44%	14,940 $1.6 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $1.04 Million - $1.22 Million	12,103 New	12,103 $1.06 Million

Others Institutions Holding ABBV

# of Institutions

4,078

Shares Held

1.28B

Call Options Held

16.9M

Put Options Held

15.1M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Alliance, LLC with notifications on news.

Account

Founders Financial Alliance, LLC Abb Vie Inc. Transaction History